AccueilSTAR • NSE
add
Strides Arcolab
Dernière clôture
572,75 ₹
Variation sur la journée
564,95 ₹ - 616,50 ₹
Plage sur l'année
324,70 ₹ - 804,00 ₹
Capitalisation boursière
56,13 Md INR
Volume moyen
687,71 k
Ratio cours/bénéfices
24,22
Rendement (dividendes)
0,41 %
Place boursière principale
NSE
Actualités
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
(INR) | sept. 2024info | Variation Y/Y |
---|---|---|
Chiffre d'affaires | 12,01 Md | 20,18 % |
Charges d'exploitation | 5,18 Md | 6,06 % |
Résultat net | 932,32 M | 170,98 % |
Marge bénéficiaire nette | 7,76 | 159,06 % |
Bénéfice par action | — | — |
EBITDA | 2,35 Md | 53,62 % |
Taux d'imposition effectif | 18,46 % | — |
Bilan
Total des actifs
Total du passif
(INR) | sept. 2024info | Variation Y/Y |
---|---|---|
Trésorerie/Invest. court terme | 2,47 Md | -24,31 % |
Total des actifs | 59,90 Md | -5,49 % |
Total du passif | 37,75 Md | -13,11 % |
Total des capitaux propres | 22,15 Md | — |
Actions en circulation | 91,94 M | — |
Ratio cours/valeur comptable | 2,32 | — |
Rentabilité des actifs | — | — |
Retour sur capitaux | 10,17 % | — |
Flux de trésorerie
Variation nette en trésorerie
(INR) | sept. 2024info | Variation Y/Y |
---|---|---|
Résultat net | 932,32 M | 170,98 % |
Trésorerie (opérations) | — | — |
Trésorerie (invest.) | — | — |
Trésorerie (financement) | — | — |
Variation nette en trésorerie | — | — |
Flux de trésorerie dispo. | — | — |
À propos
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Date de fondation
1990
Siège social
Site Web
Employés
3 065